Lumos Pharma News

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.

Aug 7 05:14

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Lawley Lori D

Aug 6 05:23

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.

Aug 6 05:23

Lumos Pharma | 10-Q: Q2 2024 Earnings Report

Aug 2 20:19

Lumos Pharma | 8-K: Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update

Aug 2 05:12

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Pitukcheewanont Pisit Duke

Jul 4 07:50

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director van Es-Johansson An

Jun 8 04:17

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director LALANDE KEVIN M.

Jun 8 04:15

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director Raffin Thomas A.

Jun 8 04:14

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director Zoth Lota S.

Jun 8 04:14

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON CHAD ALLEN

Jun 8 04:14

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director McCracken Joseph S

Jun 8 04:14

Lumos Pharma | 8-K: Current report

Jun 6 04:13

Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Pitukcheewanont Pisit Duke

Jun 5 05:05

Lumos Pharma | 10-Q: Q1 2024 Earnings Report

May 16 10:40

Lumos Pharma | 8-K: Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results

May 15 22:00

Lumos Pharma | 10-K/A: Annual report (Amendment)

Apr 23 04:32

Lumos Pharma | 8-K: Current report

Apr 19 04:57

Lumos Pharma | ARS: Annual Report to Security Holders

Apr 16 04:35

Lumos Pharma | DEFA14A: Others

Apr 13 05:29